NCT00014391View on ClinicalTrials.gov

Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

February 28, 1999

Primary Completion Date

October 31, 2001

Study Completion Date

October 31, 2001

Conditions
Cancer
Interventions
BIOLOGICAL

palivizumab

DRUG

ribavirin

Trial Locations (1)

98109

Fred Hutchinson Cancer Research Center, Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fred Hutchinson Cancer Center

OTHER